IFCC Survey on Impact of COVID-19 on Clinical Laboratories now available in:
please DISTRIBUTE this survey to your membership
and all clinical laboratories in your country
The current worldwide COVID-19 epidemic has had a significant impact on clinical laboratories globally and has highlighted the critical role of laboratory medicine in public health and patient care.
IFCC has responded by developing an IFCC Information Guide on COVID-19 (www.ifcc.org) as well as a Special Taskforce to provide guidelines to clinical laboratories around the world.
IFCC would now like to survey all colleagues in clinical laboratories in each country to understand how individual laboratories manage pre-analytical, analytical and post-analytical processes during the COVID-19 outbreak.
The questions raised are aimed at capturing what your laboratory is currently doing to mitigate the biohazards related to COVID-19. This survey has been developed with assistance of APFCB as well as IFCC Taskforce on COVID-19.
Please complete and distribute the following survey to all clinical colleagues in your country. We have received a strong response rate but would like to hear from all member countries to ensure wide representation from across the IFCC community.
Requested completion extended to Friday 1st May 2020.
We look forward to receiving feedback from all national societies and their clinical laboratories.
Thank you for participating in this important and urgent survey.
Prof. Maurizio Ferrari Prof. Khosrow Adeli
IFCC President IFCC President-elect
The IFCC thanks all professionals committed in the fight to COVID-19 worldwide